NO163356C - Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament. - Google Patents

Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.

Info

Publication number
NO163356C
NO163356C NO833961A NO833961A NO163356C NO 163356 C NO163356 C NO 163356C NO 833961 A NO833961 A NO 833961A NO 833961 A NO833961 A NO 833961A NO 163356 C NO163356 C NO 163356C
Authority
NO
Norway
Prior art keywords
principly
medicine
release
procedure
preparation
Prior art date
Application number
NO833961A
Other languages
English (en)
Other versions
NO163356B (no
NO833961L (no
Inventor
Michael A Zoglio
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO833961L publication Critical patent/NO833961L/no
Publication of NO163356B publication Critical patent/NO163356B/no
Publication of NO163356C publication Critical patent/NO163356C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO833961A 1982-11-01 1983-10-31 Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament. NO163356C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43810082A 1982-11-01 1982-11-01
US53612883A 1983-09-27 1983-09-27

Publications (3)

Publication Number Publication Date
NO833961L NO833961L (no) 1984-05-02
NO163356B NO163356B (no) 1990-02-05
NO163356C true NO163356C (no) 1990-05-16

Family

ID=27031546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833961A NO163356C (no) 1982-11-01 1983-10-31 Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.

Country Status (13)

Country Link
EP (1) EP0111144B1 (no)
KR (1) KR900007311B1 (no)
AU (1) AU554377B2 (no)
CA (1) CA1220137A (no)
DE (1) DE3368011D1 (no)
DK (1) DK499183A (no)
ES (1) ES8607008A1 (no)
GR (1) GR78740B (no)
IE (1) IE56182B1 (no)
IL (1) IL70071A (no)
NO (1) NO163356C (no)
NZ (1) NZ206094A (no)
PH (1) PH20332A (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4749576A (en) * 1984-05-10 1988-06-07 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
EP0467488B1 (en) * 1984-08-17 1995-10-11 The Wellcome Foundation Limited Composition for the controlled discharge of an active ingredient
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
SK279684B6 (sk) * 1993-06-14 1999-02-11 Janssen Pharmaceutica N.V. Tableta a spôsob jej výroby
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
DE19608423A1 (de) * 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
CA2464653C (en) * 2001-10-29 2011-10-18 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
MX2009013384A (es) 2007-06-08 2010-01-25 Addrenex Pharmaceuticals Inc Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica.
WO2012085656A2 (en) 2010-12-22 2012-06-28 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
KR20140075807A (ko) 2010-12-23 2014-06-19 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
CA2978680A1 (en) 2015-03-04 2016-09-09 Arnold Forbes Compositions and methods for treating drug addiction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139869A (en) * 1966-01-06 1969-01-15 Moore Medicinal Products Ltd Improvements in or relating to tablets
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator

Also Published As

Publication number Publication date
IL70071A (en) 1987-12-31
DK499183A (da) 1984-05-02
ES526901A0 (es) 1986-06-16
EP0111144A1 (en) 1984-06-20
IL70071A0 (en) 1984-01-31
AU2080383A (en) 1984-05-10
GR78740B (no) 1984-10-02
KR840006765A (ko) 1984-12-03
NO163356B (no) 1990-02-05
DE3368011D1 (en) 1987-01-15
DK499183D0 (da) 1983-10-31
PH20332A (en) 1986-12-02
KR900007311B1 (ko) 1990-10-08
AU554377B2 (en) 1986-08-21
ES8607008A1 (es) 1986-06-16
NO833961L (no) 1984-05-02
IE832543L (en) 1984-05-01
IE56182B1 (en) 1991-05-08
CA1220137A (en) 1987-04-07
NZ206094A (en) 1986-10-08
EP0111144B1 (en) 1986-12-03

Similar Documents

Publication Publication Date Title
NO163356C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.
DE3269625D1 (en) Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use
NO822556L (no) Fremgangsmaate for fremstilling av inhaleringslegemidler
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
NO871791D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syrelabile stoffer for oral anvendelse.
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
IT8322832A0 (it) Dispositivo per la somministrazione controllata di farmaci.
ES524892A0 (es) Un procedimiento para la preparacion de una tableta farmaceutica
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
IT1168734B (it) Cefem composti ad attivita' farmaceutica e procedimenti per la loro preparazione
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
NO874200L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO875359L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
MY8500403A (en) Ethsanolamine compounds, prolesses for their preparation, pharmaceutical preparations containing them and their medicinal use
ZA838463B (en) Heterocyclylthio compounds,processes for their manufacture,pharmaceutical preparations that contain these compounds,and the use of the latter
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.